Raymond James Financial Inc. Purchases New Shares in Patterson Companies, Inc. (NASDAQ:PDCO)

Raymond James Financial Inc. bought a new stake in Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 593,505 shares of the company's stock, valued at approximately $18,316,000. Raymond James Financial Inc. owned 0.67% of Patterson Companies as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. GAMMA Investing LLC grew its holdings in shares of Patterson Companies by 103.0% during the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company's stock valued at $41,000 after purchasing an additional 680 shares during the last quarter. Anchor Investment Management LLC increased its holdings in shares of Patterson Companies by 20.5% during the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock worth $51,000 after buying an additional 400 shares in the last quarter. KBC Group NV lifted its stake in shares of Patterson Companies by 32.7% in the 3rd quarter. KBC Group NV now owns 2,757 shares of the company's stock valued at $60,000 after acquiring an additional 680 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new position in shares of Patterson Companies in the 3rd quarter valued at $65,000. Finally, Blue Trust Inc. boosted its holdings in shares of Patterson Companies by 18.0% during the 4th quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock valued at $84,000 after acquiring an additional 417 shares in the last quarter. 85.43% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

PDCO has been the subject of a number of research reports. Morgan Stanley raised their price objective on shares of Patterson Companies from $27.00 to $31.35 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Robert W. Baird boosted their price objective on shares of Patterson Companies from $25.00 to $31.00 and gave the stock a "neutral" rating in a research note on Thursday, December 12th. StockNews.com assumed coverage on Patterson Companies in a research report on Wednesday. They set a "hold" rating for the company. Piper Sandler decreased their price target on Patterson Companies from $26.00 to $24.00 and set a "neutral" rating for the company in a research note on Friday, December 6th. Finally, Mizuho began coverage on Patterson Companies in a research report on Wednesday, December 4th. They set a "neutral" rating and a $23.00 price objective for the company. Eleven equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $26.57.

Patterson Companies Stock Down 0.1 %

Shares of NASDAQ:PDCO traded down $0.03 during trading on Friday, reaching $31.16. 2,119,163 shares of the stock were exchanged, compared to its average volume of 1,015,868. Patterson Companies, Inc. has a 1-year low of $19.45 and a 1-year high of $31.79. The stock has a fifty day moving average of $31.03 and a two-hundred day moving average of $26.11. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of 18.22, a price-to-earnings-growth ratio of 2.71 and a beta of 0.99.

Patterson Companies Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.